Inovio Pharmaceuticals (NASDAQ:INO – Get Free Report) was upgraded by StockNews.com from a “sell” rating to a “hold” rating in a report issued on Thursday. A number of other equities research analysts have also recently commented on the stock. Oppenheimer raised shares of Inovio Pharmaceuticals from a “market perform” rating to an “outperform” rating and […]